ANPCY News and Press, Angle Plc Surrey ADR From 09/02/20

GUILDFORD, SURREY / ACCESSWIRE / September 2, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 30 June 2020 on Thursday 29 October 2020. This date is in line with COVID-19 guidance provided by AIM R...

GUILDFORD, SURREY / ACCESSWIRE / August 27, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed. For further information ANGLE: About ANGLE plc ww...

BREAKTHROUGH RESEARCH SHOWS THE POTENTIAL TO USE PARSORTIX TO ASSESS WHETHER A PATIENT WILL RESPOND TO IMMUNOTHERAPY Researchers develop novel approach to characterise CTCs for both PD-L1 and IDO protein expression to predict patient response to immune checkpoint inhibitors in non-smal...

GUILDFORD, SURREY / ACCESSWIRE / August 5, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that its Annual General Meeting (AGM) will be held at 2:00 pm on Thursday 27 August 2020 as a closed meeting at ANGLE plc, 10 Nugent Road, Surrey Research Park...

RESEARCH STUDY INVESTIGATES USE OF PARSORTIX LIQUID BIOPSY FOR METASTATIC BREAST CANCER PATIENTS Pilot study compared Parsortix liquid biopsy to tissue biopsy of a metastatic site Potential actionable therapeutic targets were found in the Parsortix liquid biopsy that were missed in...

GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / ANGLE plc (OTC PINK:ANPCY)(AIM:AGL): TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a P...

GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / (OTC Pink Sheets:ANPCY)(AIM:AGL) TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Prima...

GUILDFORD, SURREY / ACCESSWIRE / July 8, 2020 / OTC Pink Sheets:ANPCY, AIM:AGL TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary...

CONTINUED PROGRESS TOWARDS FDA SUBMISSION OVARIAN CANCER STUDY IN PROGRESS GUILDFORD, SURREY / ACCESSWIRE / June 25, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world leading liquid biopsy company, today announces audited preliminary results for the eight months ended 31 December 2019. ...

MET EXPRESSION OF PARSORTIX-HARVESTED CTCs FROM CANCER PATIENTS HAS POTENTIAL AS BIOMARKER FOR MET INHIBITOR DRUG TRIALS Potential for liquid biopsy solution to drive new areas of cancer treatment Parsortix performance demonstrates key advantages over alternative approaches G...